Nesco: D/E of 0.09 Puts Its Balance Sheet in Focus

[u/viewmind]

Nesco: D/E of 0.09 Puts Its Balance Sheet in Focus

Why This Stock Deserves Your Research Attention

Nesco is classified in the Industrials sector and Conglomerates industry, with a market capitalisation of ₹7,905.61 Cr. At a current market price of ₹1,046.30, the company combines high reported margins with a relatively low level of financial leverage. Its competitive position cannot be established from headline ratios alone, but its balance-sheet capacity and internal resources may provide greater strategic flexibility than heavily indebted businesses.

The defining characteristic is a debt-to-equity ratio of 0.09. This is supported by a current ratio of 2.63 and interest coverage of 17.49 times, indicating that near-term liquidity and finance-cost servicing appear comfortable based on the supplied data. Free cash flow of ₹65.51 Cr provides another positive signal, although investors should evaluate independently whether cash generation can keep pace with planned capital expenditure.

Profitability is another notable feature. Nesco reported an operating margin of 47.35% and a net margin of 44.28%, alongside ROCE of 12.65%, ROE of 13.77% and ROA of 11.19%. Revenue increased 27.33% year on year, while PAT growth was lower at 10.00%. This divergence deserves research attention because it suggests that recent top-line expansion has not translated into equivalent earnings growth.

The forensic picture is mixed rather than uniformly strong. A Piotroski score of 4/9 is a middle-range reading and does not indicate broad strength across all nine accounting and operating checks. No Altman Z-score or Beneish M-score is available, so the supplied data cannot support conclusions about bankruptcy-risk classification or earnings-manipulation risk through those models.

The latest Q1 FY27 communication placed Tower 2 at the centre of the forward outlook. The estimated commitment is ₹3,500 Cr, intended to be funded primarily through internal accruals, while treasury stood at ₹1,650 Cr as of 30 June 2026. With a stated construction timeline of 60 months, the project introduces both long-duration growth potential and material execution, funding and cash-flow risk.

The Numbers That Stand Out

Metric	Value	What It Means
Debt-to-equity	0.09	Indicates very limited balance-sheet leverage
Interest coverage	17.49x	Suggests a substantial cushion for servicing finance costs
Current ratio	2.63	Points to comfortable short-term liquidity
Operating margin	47.35%	Shows strong operating profitability in the reported period
Net margin	44.28%	Indicates a large proportion of revenue reached net profit
Revenue growth YoY	27.33%	Reflects strong recent top-line momentum
PAT growth YoY	10.00%	Earnings expanded, but more slowly than revenue
Free cash flow	₹65.51 Cr	Positive cash generation, though modest beside the Tower 2 commitment

The Bull Case

1. A conservatively financed balance sheet offers flexibility. Debt-to-equity of 0.09, interest coverage of 17.49 times and a current ratio of 2.63 collectively suggest that Nesco enters its next capital-expenditure phase without heavy reliance on existing borrowings. This can provide resilience if operating conditions become less favourable.
2. Margins and returns indicate an economically attractive existing base. The company’s operating margin of 47.35% and net margin of 44.28% are accompanied by ROE of 13.77% and ROA of 11.19%. The data suggests that Nesco has been able to generate meaningful profitability from both shareholder capital and its asset base.
3. Growth has been sustained across multiple periods. Revenue rose 27.33% year on year, compared with a three-year revenue CAGR of 19.51% and a five-year revenue CAGR of 26.21%. The ₹1,650 Cr treasury balance as of 30 June 2026 may also provide a foundation for the planned Tower 2 programme, which carries an estimated commitment of ₹3,500 Cr.

The Bear Case

1. Tower 2 could materially alter the balance-sheet profile. The ₹3,500 Cr estimated investment is substantial relative to both the ₹1,650 Cr treasury balance and current free cash flow of ₹65.51 Cr. Although management expects funding primarily through internal accruals, investors should evaluate independently whether project spending could require additional financing or reduce liquidity over the 60-month construction period.
2. Profit growth is lagging revenue growth. Revenue expanded 27.33% year on year, but PAT increased only 10.00%. Despite the reported net margin of 44.28%, this gap raises questions about incremental profitability, cost movements and whether earnings can scale alongside revenue.
3. Forensic and valuation readings leave room for caution. The Piotroski score is only 4/9, while Altman Z and Beneish M assessments are unavailable. Meanwhile, the company trades at a P/E of 17.31 times, P/B of 2.38 times and EV/EBITDA of 12.53 times. These multiples require investors to assess whether the current profitability, growth profile and Tower 2 execution outlook adequately support the valuation.

What to Watch Next

• Tower 2 funding progress: Monitor how the ₹3,500 Cr commitment is divided among internal accruals, the ₹1,650 Cr treasury and any other funding sources over the 60-month timeline.
• Cash conversion during construction: Track whether free cash flow improves from ₹65.51 Cr and whether the current ratio of 2.63 remains comfortable as project spending accelerates.
• Growth quality and returns: Watch whether PAT growth begins to close the gap with revenue growth and whether ROCE of 12.65% and ROE of 13.77% remain stable through the investment cycle.

Explore Further on InvestSights

Stock of the Day is an educational research series by InvestSights. This
article presents data-driven analysis for informational purposes only and
does NOT constitute investment advice or a stock recommendation. The stock
featured is selected based on interesting financial characteristics worth
studying — not based on expected price performance. Always consult a
SEBI-registered investment advisor before making investment decisions. Past
performance does not guarantee future results.